Literature DB >> 19001682

A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids.

R B Patwardhan1, P K Dhakephalkar, K B Niphadkar, B A Chopade.   

Abstract

BACKGROUND &
OBJECTIVES: Antibiotic resistant bacterial nosocomial infections are a leading problem in intensive care units (ICU). Present investigation was undertaken to know antibiotic resistance in Acinetobacter baumannii and some other pathogens obtained from clinical samples from ICU causing nosocomial infections. Special emphasis was given on plasmid mediated transferable antibiotic resistance in Acinetobacter.
METHODS: The clinical specimens obtained from ICU, were investigated to study distribution of nosocomial pathogens (272) and their antibiotic resistance profile. Acinetobacter isolates were identified by API2ONE system. Antimicrobial resistance was studied with minimum inhibitory concentration (MIC) by double dilution agar plate method. The plasmid profile of 26 antibiotic resistant isolates of Acinetobacter was studied. Curing of R-plasmids was determined in three antibiotic resistant plasmid containing A. baumannii isolates. Plasmid transfer was studied by transformation.
RESULTS: Major infections found in ICU were due to Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus pyogenes. The infection rate was maximum in urinary tract (44.4%) followed by wound infections (29.4%), pneumonia (10.7%) and bronchitis (7.4%). Acinetobacter isolates displayed high level of antibiotic resistance (up to 1024microg/ml) to most of antibiotics. More than 90 per cent isolates of Acinetobacter were resistant to a minimum of 23 antibiotics. Plasmid profile of Acinetobacter isolates showed presence of 1-4 plasmids. Ethidium bromide cured plasmids pUPI280, pUPI281, pUPI282 with curing efficiencies 20, 16 and 11 per cent respectively while acridine orange cured plasmids pUPI280, pUPI281 with curing efficiencies 7 and 18 per cent retrospectively. Transformation frequency of E. coli HB101 with pUPI281 was 4.3 x 10(4) transformants/microg plasmid DNA. INTERPRETATION &
CONCLUSIONS: A. baumannii was found to be associated with urinary tract infections, respiratory tract infections, septicaemia, bacteraemia, meningitis and wound infections. A. baumannii displayed higher resistance to more number of antibiotics than other nosocomial pathogens from ICU. Antibiotic sensitivity of A. baumannii cured isolates confirmed plasmid borne nature of antibiotic resistance markers. Transfer of antibiotic resistant plasmids from Acinetobacter to other nosocomial pathogens can create complications in the treatment of the patient. Therefore, it is very important to target Acinetobacter which is associated with nosocomial infections.

Entities:  

Mesh:

Year:  2008        PMID: 19001682

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  24 in total

1.  Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm.

Authors:  Nikhil D Thawal; Ajinkya B Yele; Praveen K Sahu; Balu A Chopade
Journal:  Curr Microbiol       Date:  2012-04-26       Impact factor: 2.188

2.  Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation.

Authors:  Shweta Fulsundar; Klaus Harms; Gøril E Flaten; Pål J Johnsen; Balu Ananda Chopade; Kaare M Nielsen
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

3.  Multidrug resistant acinetobacter infection and their antimicrobial susceptibility pattern in a nigerian tertiary hospital ICU.

Authors:  Victor Ugochukwu Nwadike; Chiedozie Kingsley Ojide; Eziyi Iche Kalu
Journal:  Afr J Infect Dis       Date:  2014

4.  Characterization and genome sequencing of phage Abp1, a new phiKMV-like virus infecting multidrug-resistant Acinetobacter baumannii.

Authors:  Guangtao Huang; Shuai Le; Yizhi Peng; Yan Zhao; Supeng Yin; Lin Zhang; Xinyue Yao; Yinling Tan; Ming Li; Fuquan Hu
Journal:  Curr Microbiol       Date:  2013-01-18       Impact factor: 2.188

5.  Characterization of eDNA from the clinical strain Acinetobacter baumannii AIIMS 7 and its role in biofilm formation.

Authors:  Praveen K Sahu; Pavithra S Iyer; Amrita M Oak; Karishma R Pardesi; Balu A Chopade
Journal:  ScientificWorldJournal       Date:  2012-04-19

6.  Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii.

Authors:  Jitendra Vashist; Vishvanath Tiwari; Rituparna Das; Arti Kapil; Moganty R Rajeswari
Journal:  Indian J Med Res       Date:  2011-03       Impact factor: 2.375

7.  An MFS Transporter-Like ORF from MDR Acinetobacter baumannii AIIMS 7 Is Associated with Adherence and Biofilm Formation on Biotic/Abiotic Surface.

Authors:  Praveen K Sahu; Pavithra S Iyer; Madhumita B Gaikwad; Sheetal C Talreja; Karishma R Pardesi; Balu A Chopade
Journal:  Int J Microbiol       Date:  2012-02-20

8.  Interleukin-1 receptor antagonist gene polymorphism in patients with multidrug-resistant Acinetobacter baumannii-associated pneumonia.

Authors:  Min-Jer Hsu; Yun-Chieh Lu; Yu-Chang Hsu; Wen-Sheng Liu; Wen-Tung Wu
Journal:  Ann Thorac Med       Date:  2012-04       Impact factor: 2.219

9.  Epidemiological study of prevalence, determinants, and outcomes of infections in medical ICU at a tertiary care hospital in India.

Authors:  Rajesh Ghanshani; Rajeev Gupta; Bhagwan Swarup Gupta; Sushil Kalra; Raghubir Singh Khedar; Smita Sood
Journal:  Lung India       Date:  2015 Sep-Oct

10.  Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents.

Authors:  Sougata Ghosh; Sumersing Patil; Mehul Ahire; Rohini Kitture; Sangeeta Kale; Karishma Pardesi; Swaranjit S Cameotra; Jayesh Bellare; Dilip D Dhavale; Amit Jabgunde; Balu A Chopade
Journal:  Int J Nanomedicine       Date:  2012-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.